Evidence map›Paper›PMID 37835427›Full record

ArticleCancers2023

Reproducible Bioinformatics Analysis Workflows for Detecting

Ashlee J Thomson, Jacqueline A Rehn, Susan L Heatley, Laura N Eadie, Elyse C Page, Caitlin Schutz, Barbara J McClure, Rosemary Sutton, Luciano Dalla-Pozza, Andrew S Moore and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. B Lineage Acute Lymphoblastic Leukemia with concurrentIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ashlee J ThomsonFaculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.ORCID 0000-0002-9944-9363
Jacqueline A RehnFaculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.ORCID 0000-0001-5043-6943
Susan L HeatleyFaculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.ORCID 0000-0001-7497-6477
Laura N EadieFaculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.ORCID 0000-0003-1912-7602
Elyse C PageFaculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
Caitlin SchutzBlood Cancer Program, Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA 5000, Australia.
Barbara J McClureFaculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.ORCID 0000-0002-5201-4127
Rosemary SuttonMolecular Diagnostics, Children's Cancer Institute, Kensington, NSW 2750, Australia.
Luciano Dalla-PozzaThe Cancer Centre for Children, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia.
Andrew S MooreOncology Service, Children's Health Queensland Hospital and Health Service, Brisbane, QLD 4101, Australia.
Matthew GreenwoodDepartment of Haematology and Transfusion Services, Royal North Shore Hospital, Sydney, NSW 2065, Australia.
Rishi S KotechaDepartment of Clinical Haematology, Oncology, Blood and Marrow Transplantation, Perth Children's Hospital, Perth, WA 6009, Australia.ORCID 0000-0003-1836-4075
Chun Y FongDepartment of Clinical Haematology, Austin Health, Heidelberg, VIC 3083, Australia.ORCID 0000-0001-5773-103X
Agnes S M YongFaculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
David T YeungFaculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
James BreenBlack Ochre Data Labs, Indigenous Genomics, Telethon Kids Institute, Adelaide, SA 5000, Australia.
Deborah L WhiteFaculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.ORCID 0000-0003-4844-333X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B-cell acute lymphoblastic leukaemia (B-ALL) is characterised by diverse genomic alterations, the most frequent being gene fusions detected via transcriptomic analysis (mRNA-seq). Due to its hypervariable nature, gene fusions involving the Immunoglobulin Heavy Chain (

Indexed as

B-cell acute lymphoblastic leukaemiagene fusionIGHworkflow

Identifiers

PMID37835427
PMCPMC10571859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.